{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T15:23:49Z","timestamp":1769181829033,"version":"3.49.0"},"reference-count":130,"publisher":"Bentham Science Publishers Ltd.","issue":"1","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CDR"],"published-print":{"date-parts":[[2019,12,13]]},"abstract":"<jats:sec>\n<jats:title>Background:<\/jats:title>\n<jats:p>The diabetic Charcot foot syndrome is a serious and potentially limbthreatening\nlower-extremity complication of diabetes.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Introduction:<\/jats:title>\n<jats:p>The present review provides a concise account of the advances made over the last twentyfive\nyears in understanding the pathogenesis and management of Charcot neuroarthropathy (CN).<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Methods:<\/jats:title>\n<jats:p>In this study, the widely known pathogenetic mechanisms underpinning CN are brought into\nfocus, particularly the role of RANKL\/RANK\/OPG system and advanced glycation end production in\nthe pathogenesis of CN. Furthermore, other potential triggering factors, namely nitric oxide, endothelial\ndysfunction, macro calcifications and body weight that influence CN have also been discussed.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Results:<\/jats:title>\n<jats:p>The wide range of diagnostic tools available to clinicians for accurate staging of this pathology\nhas been examined, particularly radiological and nuclear medicine imaging. Additionally, the difficult\ndifferential diagnosis between osteomyelitis and CN is also elucidated.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Conclusions:<\/jats:title>\n<jats:p> The review concludes with the comprehensive summary of the major promising therapeutic\nstrategies, including conservative treatment involving orthopedic devices, pharmacological approach,\nand the most common surgical techniques currently employed in the diagnosis and treatment of\nthis acute disease.<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/1573399815666190502121945","type":"journal-article","created":{"date-parts":[[2019,5,3]],"date-time":"2019-05-03T07:37:57Z","timestamp":1556869077000},"page":"62-72","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["Charcot Neuroarthropathy: From the Laboratory to the Bedside"],"prefix":"10.2174","volume":"16","author":[{"given":"Dario","family":"Pitocco","sequence":"first","affiliation":[{"name":"Diabetes Care Unit, Institute of Endocrinology, Catholic University of Sacred Heart, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giuseppe","family":"Scavone","sequence":"additional","affiliation":[{"name":"Diabetes Care Unit, Institute of Endocrinology, Catholic University of Sacred Heart, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mauro","family":"Di Leo","sequence":"additional","affiliation":[{"name":"Diabetes Care Unit, Institute of Endocrinology, Catholic University of Sacred Heart, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raffaele","family":"Vitiello","sequence":"additional","affiliation":[{"name":"Diabetes Care Unit, Institute of Endocrinology, Catholic University of Sacred Heart, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alessandro","family":"Rizzi","sequence":"additional","affiliation":[{"name":"Diabetes Care Unit, Institute of Endocrinology, Catholic University of Sacred Heart, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Linda","family":"Tartaglione","sequence":"additional","affiliation":[{"name":"Diabetes Care Unit, Institute of Endocrinology, Catholic University of Sacred Heart, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Federica","family":"Costantini","sequence":"additional","affiliation":[{"name":"Diabetes Care Unit, Institute of Endocrinology, Catholic University of Sacred Heart, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea","family":"Flex","sequence":"additional","affiliation":[{"name":"Institute of Internal Medicine, Catholic University of Sacred Heart, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marco","family":"Galli","sequence":"additional","affiliation":[{"name":"Institute of Orthopedic Surgery, Catholic University of Sacred Heart, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Salvatore","family":"Caputo","sequence":"additional","affiliation":[{"name":"Diabetes Care Unit, Institute of Endocrinology, Catholic University of Sacred Heart, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giovanni","family":"Ghirlanda","sequence":"additional","affiliation":[{"name":"Diabetes Care Unit, Institute of Endocrinology, Catholic University of Sacred Heart, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alfredo","family":"Pontecorvi","sequence":"additional","affiliation":[{"name":"Diabetes Care Unit, Institute of Endocrinology, Catholic University of Sacred Heart, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"965","reference":[{"key":"ref=1","first-page":"161","volume":"1","author":"Charcot J.","year":"1868","unstructured":"Charcot J.; Sur quelquesarthropathies qui paraissentdependred\u2019une lesion du cerveauou de la moelleepiniere. Arch Des Phys Norm Pathol 1868,1,161","journal-title":"Arch Des Phys Norm Pathol"},{"key":"ref=2","doi-asserted-by":"crossref","first-page":"59","DOI":"10.4239\/wjd.v2.i5.59","volume":"2","author":"Gouveri E.","year":"2011","unstructured":"Gouveri E.; Papanas N.; Charcot osteoarthropathy in diabetes: a brief review with an emphasis on clinical practice. World J Diabetes 2011,2,59-65","journal-title":"World J Diabetes"},{"key":"ref=3","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1053\/j.semvascsurg.2012.05.001","volume":"25","author":"Malhotra S.","year":"2012","unstructured":"Malhotra S.; Bello E.; Kominsky S.; Diabetic foot ulcerations: biomechanics, charcot foot, and total contact cast. Semin Vasc Surg 2012,25,66-69","journal-title":"Semin Vasc Surg"},{"key":"ref=4","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1503\/cmaj.111972","volume":"184","author":"Mumoli N.","year":"2012","unstructured":"Mumoli N.; Camaiti A.; Charcot foot. CMAJ 2012,184,1392","journal-title":"CMAJ"},{"key":"ref=5","doi-asserted-by":"crossref","first-page":"2123","DOI":"10.2337\/dc11-0844","volume":"34","author":"Rogers L.C.","year":"2011","unstructured":"Rogers L.C.; Frykberg R.G.; Armstrong D.G.; The Charcot foot in diabetes. Diabetes Care 2011,34,2123-2129","journal-title":"Diabetes Care"},{"key":"ref=6","first-page":"439","author":"Sanders L.F.","year":"2001","unstructured":"Sanders L.F.; Charcot neuroathropathy of the foot. The diabetic foot 2001,439-466","journal-title":"The diabetic foot"},{"key":"ref=7","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1007\/s00402-006-0271-x","volume":"127","author":"Chantelau E.","year":"2007","unstructured":"Chantelau E.; Richter A.; Ghassem-Zadeh N.; Poll L.W.; \u201cSilent\u201d bone stress injuries in the feet of diabetic patients with polyneuropathy: a report on 12 cases. Arch Orthop Trauma Surg 2007,127,171-177","journal-title":"Arch Orthop Trauma Surg"},{"key":"ref=8","first-page":"307","volume":"57","author":"Jordan W.R.","year":"1936","unstructured":"Jordan W.R.; Neuritic Manifestation in Diabetes Mellitus. Arc. Int Med 1936,57,307-366","journal-title":"Int Med"},{"key":"ref=9","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1177\/1938640011434502","volume":"5","author":"Suder N.C.","year":"2012","unstructured":"Suder N.C.; Wukich D.K.; Prevalence of diabetic neuropathy in patients undergoing foot and ankle surgery. Foot Ankle Spec 2012,5,97-101","journal-title":"Foot Ankle Spec"},{"key":"ref=10","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1007\/s00125-002-0885-7","volume":"45","author":"Rajbhandari S.J.","year":"2002","unstructured":"Rajbhandari S.J.; Jenkins R.C.; Davies C.; Tesfaye S.; Charcot neuroarthropathy in diabetes mellitus. Diabetologia 2002,45,1085-1096","journal-title":"Diabetologia"},{"key":"ref=11","doi-asserted-by":"crossref","first-page":"S59","DOI":"10.1002\/1520-7560(200009\/10)16:1+<::AID-DMRR134>3.0.CO;2-N","volume":"16","author":"Frykberg R.G.","year":"2000","unstructured":"Frykberg R.G.; Mendeszoon E.; Management of the diabetic Charcot foot. Diabetes Metab Res Rev 2000,16,S59-S66","journal-title":"Diabetes Metab Res Rev"},{"key":"ref=12","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1177\/107110078300400104","volume":"4","author":"Cofield R.H.","year":"1983","unstructured":"Cofield R.H.; Motrisin M.; Beabout J.W.; Diabetic neuroarthropathy in the foot: patient characteristics and patterns of radiographic changes. Foot Ankle Int 1983,4,15-22","journal-title":"Foot Ankle Int"},{"key":"ref=13","doi-asserted-by":"crossref","first-page":"796","DOI":"10.2337\/diacare.23.6.796","volume":"23","author":"Fabrin J.","year":"2000","unstructured":"Fabrin J.; Larsen K.; Holstein P.; Long-term follow-up in diabetic Charcot feet with spontaneous onset. Diabetes Care 2000,23,796-800","journal-title":"Diabetes Care"},{"key":"ref=14","doi-asserted-by":"crossref","first-page":"1776","DOI":"10.1016\/S0140-6736(02)11671-0","volume":"360","author":"Hartemann-Heurtier A.","year":"2002","unstructured":"Hartemann-Heurtier A.; Ha Van G.; Grimaldi A.; The Charcot foot. Lancet 2002,360,1776-1779","journal-title":"Lancet"},{"key":"ref=15","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/S1067-2516(99)80086-6","volume":"38","author":"Sella E.J.","year":"1999","unstructured":"Sella E.J.; Barrette C.; Staging of Charcot neuroarthropathy along the medial column of the foot in the diabetic patient. J Foot Ankle Surg 1999,38,34-40","journal-title":"J Foot Ankle Surg"},{"key":"ref=16","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1097\/00005792-197205000-00006","volume":"51","author":"Sinha S.","year":"1971","unstructured":"Sinha S.; Munichoodappa C.; Kozak G.; Neuro-arthropathy (Charcot joints) in diabetes mellitus. Medicine 1971,51,191-210","journal-title":"Medicine"},{"key":"ref=17","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1002\/(SICI)1096-9136(199705)14:5<357::AID-DIA341>3.0.CO;2-8","volume":"14","author":"Armstrong D.G.","year":"1997","unstructured":"Armstrong D.G.; Todd W.F.; Lavery L.A.; Harkless L.B.; Bushman T.R.; The natural history of acute Charcot\u2019s arthropathy in a diabetic foot specialty clinic. Diabet Med 1997,14,357-363","journal-title":"Diabet Med"},{"key":"ref=18","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.2106\/00004623-198870080-00010","volume":"70","author":"Clohisy D.R.","year":"1988","unstructured":"Clohisy D.R.; Thompson R.C.; Fractures associated with neuropathic arthropathy in adults who have juvenile-onset diabetes. J Bone Joint Surg Am 1988,70,1192-1200","journal-title":"J Bone Joint Surg Am"},{"key":"ref=19","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1097\/00003086-199812000-00016","author":"Bayne O.","year":"1998","unstructured":"Bayne O.; Lu E.J.; Diabetic Charcot\u2019s arthropathy of the wrist. Case report and literature review. Clin Orthop Relat Res 1998(357),122-126","journal-title":"Clin Orthop Relat Res"},{"key":"ref=20","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1046\/j.1464-5491.2002.00704.x","volume":"19","author":"Lambert A.P.","year":"2002","unstructured":"Lambert A.P.; Close C.F.; Charcot neuroarthropathy of the knee in type 1 diabetes: treatment with total knee arthroplasty. Diabet Med 2002,19,338-341","journal-title":"Diabet Med"},{"key":"ref=21","doi-asserted-by":"crossref","first-page":"997","DOI":"10.2337\/dc06-2168","volume":"30","author":"Petrova N.L.","year":"2007","unstructured":"Petrova N.L.; Moniz C.; Elias D.A.; Buxton-Thomas M.; Bates M.; Edmonds M.E.; Is there a systemic inflammatory response in the acute charcot foot? Diabetes Care 2007,30,997-998","journal-title":"Diabetes Care"},{"key":"ref=22","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1177\/107110070502600109","volume":"26","author":"Trepman E.","year":"2005","unstructured":"Trepman E.; Nihal A.; Pinzur M.S.; Current Topics Review: Charcot Neuroarthropathy of the Foot and Ankle. Foot Ankle Int 2005,26,46-63","journal-title":"Foot Ankle Int"},{"key":"ref=23","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1097\/00003086-200506000-00026","author":"Saltzman C.L.","year":"2005","unstructured":"Saltzman C.L.; Hagy M.L.; Zimmerman B.; How effective is intensive nonoperative initial treatment of patients with diabetes and Charcot arthropathy of the feet? Clin Orthop Relat Res 2005(435),185-190","journal-title":"Clin Orthop Relat Res"},{"key":"ref=24","first-page":"3","author":"Musa H.G.","year":"2012","unstructured":"Musa H.G.; Ahmed M.E.; Associated risk factors and management of chronic diabetic foot ulcers exceeding 6 months\u2019 duration. Diabet Foot Ankle 2012,3","journal-title":"Diabet Foot Ankle"},{"key":"ref=25","doi-asserted-by":"crossref","first-page":"816","DOI":"10.2337\/dc08-1695","volume":"32","author":"Sohn M.W.","year":"2009","unstructured":"Sohn M.W.; Todd A.L.; Rodney M.S.; Mortality risk of charcot arthropathy compared with that of diabetic foot ulcer and diabetes alone. Diabetes Care 2009,32,816-821","journal-title":"Diabetes Care"},{"key":"ref=26","doi-asserted-by":"crossref","first-page":"98","DOI":"10.2337\/dc09-1497","volume":"33","author":"Sohn M.W.","year":"2010","unstructured":"Sohn M.W.; Stuck R.M.; Pinzur M.; Lee T.A.; Budiman-Mak E.; Lower-extremity amputation risk after Charcot arthropathy and diabetic foot ulcer. Diabetes Care 2010,33,98-100","journal-title":"Diabetes Care"},{"key":"ref=27","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1111\/j.1464-5491.2011.03539.x","volume":"29","author":"Rudrappa S.","year":"2012","unstructured":"Rudrappa S.; Game F.; Jeffcoate W.J.; Recurrence of the acute Charcot foot in diabetes. Diabet Med 2012,29,819-821","journal-title":"Diabet Med"},{"key":"ref=28","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1111\/dme.12754","volume":"32","author":"Jeffcoate W.J.","year":"2015","unstructured":"Jeffcoate W.J.; Charcot foot syndrome. Diabet Med 2015,32,760-770","journal-title":"Diabet Med"},{"key":"ref=29","doi-asserted-by":"crossref","first-page":"S58","DOI":"10.1002\/dmrr.846","volume":"24","author":"Petrova N.L.","year":"2008","unstructured":"Petrova N.L.; Edmonds M.E.; Charcot neuro\u2010osteoarthropathy-current standards. Diabetes Metab Res and Rev 2008,24,S58-S61","journal-title":"Diabetes Metab Res and Rev"},{"key":"ref=30","first-page":"297","author":"Sanders L.J.","year":"1998","unstructured":"Sanders L.J.; Frykberg R.G.; Diabetic neuropathic osteoarthropathy: the Charcot foot. The high risk foot in diabetes mellitus 1998,297-338","journal-title":"The high risk foot in diabetes mellitus"},{"key":"ref=31","doi-asserted-by":"crossref","first-page":"2123","DOI":"10.2337\/dc11-0844","volume":"34","author":"Rogers L.C.","year":"2011","unstructured":"Rogers L.C.; Frykberg R.G.; Armstrong D.G.; The charcot foot in diabetes. Diabetes Care 2011,34,2123-2129","journal-title":"Diabetes Care"},{"key":"ref=32","author":"Eichenholtz S.N.","year":"1966","unstructured":"Eichenholtz S.N.;  Charcot joints With a foreword by PD Wilson\nSpringfield [III] 1966","journal-title":"Charcot joints With a foreword by PD Wilson\nSpringfield [III]"},{"key":"ref=33","doi-asserted-by":"crossref","first-page":"749","DOI":"10.2106\/00004623-199072050-00016","volume":"72","author":"Shibata T.","year":"1990","unstructured":"Shibata T.; Tada K.; Hashizume C.; The results of arthrodesis of the ankle for leprotic neuro-arthropathy. J Bone Joint Surg Am 1990,72,749-756","journal-title":"J Bone Joint Surg Am"},{"key":"ref=34","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1016\/S0033-8389(02)00036-2","volume":"40","author":"Morrison W.B.","year":"2002","unstructured":"Morrison W.B.; Ledermann H.P.; Work-up of the diabetic foot. Radiol Clin North Am 2002,40,1171-1192","journal-title":"Radiol Clin North Am"},{"key":"ref=35","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.2337\/diacare.27.5.1235-a","volume":"27","author":"Petrova N.L.","year":"2004","unstructured":"Petrova N.L.; Foster A.V.; Edmonds M.E.; Difference in presentation of Charcot osteoarthropathy in type 1 compared with type 2 diabetes. Diabetes Care 2004,27,1235-1236","journal-title":"Diabetes Care"},{"key":"ref=36","doi-asserted-by":"crossref","first-page":"6418","DOI":"10.3402\/dfa.v2i0.6418","volume":"2","author":"Ramanujam C.L.","year":"2011","unstructured":"Ramanujam C.L.; Facaros Z.; An overview of conservative treatment options for diabetic Charcot foot neuroarthropathy. Diabet Foot Ankle 2011,2,6418","journal-title":"Diabet Foot Ankle"},{"key":"ref=37","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1177\/107110070602700503","volume":"27","author":"Pinzur M.S.","year":"2006","unstructured":"Pinzur M.S.; Lio T.; Posner M.; Treatment of Eichenholtz stage I Charcot foot arthropathy with a weightbearing total contact cast. Foot Ankle Int 2006,27,324-329","journal-title":"Foot Ankle Int"},{"key":"ref=38","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1055\/s-2006-924229","volume":"114","author":"Chantelau D.","year":"2006","unstructured":"Chantelau D.; Poll L.W.; Evaluation of the diabetic Charcot foot by MR imaging or plain radiography\u2014an observational study. Exp Clin Endocrinol Diabetes 2006,114,428-431","journal-title":"Exp Clin Endocrinol Diabetes"},{"key":"ref=39","first-page":"529A","volume":"40","author":"Saunders L.J.","year":"1991","unstructured":"Saunders L.J.; Mrdjenovich D.; Anatomical patterns of bone and joint destruction in neuropathic diabetics. Diabetes 1991,40,529A","journal-title":"Diabetes"},{"key":"ref=40","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1007\/s00125-002-0885-7","volume":"45","author":"Rajbhandari S.M.","year":"2002","unstructured":"Rajbhandari S.M.; Jenkins R.C.; Davies C.; Tesfaye S.; Charcot neuroarthropathy in diabetes mellitus. Diabetologia 2002,45,1085-1096","journal-title":"Diabetologia"},{"key":"ref=41","first-page":"1281","author":"Brodsky J.W.","year":"2002","unstructured":"Brodsky J.W.; The diabetic foot. Surgery of the foot and ankle 2002,1281-1368","journal-title":"Surgery of the foot and ankle"},{"key":"ref=42","first-page":"21","author":"Brodsky J.W.","year":"1993","unstructured":"Brodsky J.W.; Rouse A.M.; Exostectomy for symptomatic bony prominences in diabetic Charcot feet. Clin Orthop Relat Res 1993(296),21-26","journal-title":"Clin Orthop Relat Res"},{"key":"ref=43","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1053\/j.jfas.2008.05.009","volume":"47","author":"La Fontaine J.","year":"2008","unstructured":"La Fontaine J.; Harkless L.B.; Sylvia V.L.; Carnes D.; Heim-Hall J.; Jude E.; Levels of endothelial nitric oxide synthase and calcitonin gene-related peptide in the Charcot foot: a pilot study. J Foot Ankle Surg 2008,47,424-429","journal-title":"J Foot Ankle Surg"},{"key":"ref=44","doi-asserted-by":"crossref","first-page":"2058","DOI":"10.1016\/S0140-6736(05)67029-8","volume":"10","author":"Jeffcoate W.J.","year":"2005","unstructured":"Jeffcoate W.J.; Game F.; Cavanagh P.R.; The role of proinflammatory cytokines in the cause of neuropathic osteoarthropathy (acute Charcot foot) in diabetes. Lancet 2005,10(366),2058-2061","journal-title":"Lancet"},{"key":"ref=45","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1007\/s00125-008-0992-1","volume":"51","author":"Mabilleau G.","year":"2008","unstructured":"Mabilleau G.; Petrova N.; Edmonds M.E.; Sabokar A.; Increased osteoclastic activity in acute Charcot\u2019s osteoarthropathy: the role of receptor activator of nuclear factor-kappaB ligand. Diabetologia 2008,51,1035-1040","journal-title":"Diabetologia"},{"key":"ref=46","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1007\/s00125-004-1477-5","volume":"47","author":"Jeffcoate W.","year":"2004","unstructured":"Jeffcoate W.; Vascular calcification and osteolysis in diabetic neuropathy-is RANK-L the missing link? Diabetologia 2004,47,1488-1492","journal-title":"Diabetologia"},{"key":"ref=47","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1002\/(SICI)1096-9136(199707)14:7<527::AID-DIA404>3.0.CO;2-Q","volume":"14","author":"Gough A.","year":"1997","unstructured":"Gough A.; Abraha G.H.; Li F.; Purewal T.S.; Foster A.V.M.; Watkins P.J.; Moniz C.; Edmonds M.E.; Measurement of Markers of Osteoclast and Osteoblast Activity in Patients with Acute and Chronic Diabetic Charcot Neuroarthropathy. Diabet Med 1997,14,527-531","journal-title":"Diabet Med"},{"key":"ref=48","doi-asserted-by":"crossref","first-page":"ii32","DOI":"10.1136\/ard.61.suppl_2.ii32","volume":"61","author":"Jones D.H.","year":"2002","unstructured":"Jones D.H.; Kong Y.Y.; Penninger J.M.; Role of RANKL and RANK in bone loss and arthritis. Ann Rheum Dis 2002,61(Suppl. 2),ii32-ii39","journal-title":"Ann Rheum Dis"},{"key":"ref=49","doi-asserted-by":"crossref","DOI":"10.2337\/dc10-1695","volume":"34","author":"Mabilleau G.","year":"2011","unstructured":"Mabilleau G.; Petrova N.; Edmonds M.E.; Sabokbar A.; Number of Circulating CD14-Positive Cells and the Serum Levels of TNF-a Are Raised in Acute Charcot Foot. Diabetes Care 2011,34(3)","journal-title":"Diabetes Care"},{"key":"ref=50","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1210\/endo.139.3.5837","volume":"139","author":"Yasuda H.","year":"1998","unstructured":"Yasuda H.; Shima N.; Nakagawa N.; Identity of osteoclastogenesisinhibitory factor (OCIF) and osteoprotegerin (OPG): a mechanism by which OPG\/OCIF inhibits osteoclastogenesis in vitro. Endocrinology 1998,139,1329-1337","journal-title":"Endocrinology"},{"key":"ref=51","doi-asserted-by":"crossref","first-page":"1850","DOI":"10.1359\/JBMR.040817","volume":"19","author":"Chipoy C.","year":"2004","unstructured":"Chipoy C.; Berreur M.; Couillaud S.; Downregulation of osteoblast markers and induction of the glial fibrillary acidic protein by oncostatin M in osteosarcoma cells require PKCdelta and STAT3. J Bone Miner Res 2004,19,1850-1861","journal-title":"J Bone Miner Res"},{"key":"ref=52","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.yfrne.2008.10.001","volume":"30","author":"Goshen I.","year":"2009","unstructured":"Goshen I.; Yirmiya R.; Interleukin-1 [IL-1]: A central regulator of stress responses. Front Neuroendocrinol 2009,30,30-45","journal-title":"Front Neuroendocrinol"},{"key":"ref=53","doi-asserted-by":"crossref","first-page":"2187","DOI":"10.2337\/db10-1220","volume":"60","author":"Ndip A.","year":"2011","unstructured":"Ndip A.; Williams A.; Jude E.B.; The RANKL\/RANK\/OPG signaling pathway mediates medial arterial calcification in diabetic charcot neuroarthropathy. Diabetes 2011,60,2187-2196","journal-title":"Diabetes"},{"key":"ref=54","doi-asserted-by":"crossref","first-page":"1694","DOI":"10.2337\/dc09-0243","volume":"32","author":"Pitocco D.","year":"2009","unstructured":"Pitocco D.; Zelano G.; Gioffr\u00e9 G.; Association between osteoprotegerin G1181C and T245G polymorphisms and diabetic charcot neuroarthropathy. a case-control study. Diabetes Care 2009,32,1694-1697","journal-title":"Diabetes Care"},{"key":"ref=55","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.cpm.2007.10.001","volume":"25","author":"Frykberg R.G.","year":"2008","unstructured":"Frykberg R.G.; Belczyk R.; Epidemiology of the Charcot foot. Clin Podiatr Med Surg 2008,25,17-28","journal-title":"Clin Podiatr Med Surg"},{"key":"ref=56","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1002\/jbmr.5650110709","volume":"11","author":"Katayama Y.","year":"1996","unstructured":"Katayama Y.; Akatsu T.; Yamamoto M.; Kugai N.; Nagata N.; Role of nonenzymatic glycosylation of type I collagen in diabetic osteopenia. J Bone Miner Res 1996,11,931-937","journal-title":"J Bone Miner Res"},{"key":"ref=57","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/S8756-3282(97)00128-2","volume":"21","author":"Katayama Y.","year":"1997","unstructured":"Katayama Y.; Celic S.; Nagata N.; Martin T.J.; Findlay D.M.; Nonenzymatic glycation of type I collagen modifies interaction with UMR 201-10B preosteoblastic cells. Bone 1997,21,237-242","journal-title":"Bone"},{"key":"ref=58","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/1471-2121-2-16","volume":"2","author":"McCarthy A.D.","year":"2001","unstructured":"McCarthy A.D.; Etcheverry S.B.; Bruzzone L.; Lettieri G.; Barrio D.A.; Cortizo A.M.; Non-enzymatic glycosylation of a type I collagen matrix: effects on osteoblastic development and oxidative stress. BMC Cell Biol 2001,2,16","journal-title":"BMC Cell Biol"},{"key":"ref=59","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1007\/s005920170007","volume":"38","author":"McCarthy A.D.","year":"2001","unstructured":"McCarthy A.D.; Etcheverry S.B.; Cortizo A.M.; Effect of advanced glycation endproducts on the secretion of insulin-like growth factor-I and its binding proteins: role in osteoblast development. Acta Diabetol 2001,38,113-122","journal-title":"Acta Diabetol"},{"key":"ref=60","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1016\/j.biocel.2003.09.006","volume":"36","author":"McCarthy A.D.","year":"2004","unstructured":"McCarthy A.D.; Uemura T.; Etcheverry S.B.; Cortizo A.M.; Advanced glycation endproducts interfere with integrin-mediated osteoblastic attachment to a type-I collagen matrix. Int J Biochem Cell Biol 2004,36,840-848","journal-title":"Int J Biochem Cell Biol"},{"key":"ref=61","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.bone.2006.09.011","volume":"40","author":"Alikhani M.","year":"2007","unstructured":"Alikhani M.; Alikhani Z.; Boyd Z.C.; Advanced glycation end products stimulate osteoblast apoptosis via the MAP kinase and cytosolic apoptotic pathways. Bone 2007,40,345-353","journal-title":"Bone"},{"key":"ref=62","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1007\/s11010-007-9557-8","volume":"306","author":"Mercer N.","year":"2007","unstructured":"Mercer N.; Ahmed H.; Etcheverry S.B.; Vasta G.R.; Cortizo A.M.; Regulation of advanced glycation end product [AGE] receptors and apoptosis by AGEs in osteoblast-like cells. Mol Cell Biochem 2007,306,87-94","journal-title":"Mol Cell Biochem"},{"key":"ref=63","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.bone.2011.04.009","volume":"49","author":"Dong X.N.","year":"2011","unstructured":"Dong X.N.; Qin A.; Xu J.; Wang X.; In situ accumulation of advanced glycation endproducts [AGEs] in bone matrix and its correlation with osteoclastic bone resorption. Bone 2011,49,174-183","journal-title":"Bone"},{"key":"ref=64","doi-asserted-by":"crossref","DOI":"10.1002\/dmrr.2839","volume":"33","author":"Rizzo P.","year":"2017","unstructured":"Rizzo P.; Pitocco D.; Zaccardi F.; Autoantibodies to post\u2010translationally modified type I and II collagen in Charcot neuroarthropathy in subjects with type 2 diabetes mellitus. Diabetes Metab Res Rev 2017,33","journal-title":"Diabetes Metab Res Rev"},{"key":"ref=65","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1161\/01.ATV.18.8.1292","volume":"18","author":"Tamaru M.","year":"1998","unstructured":"Tamaru M.; Tomura K.; Sakamoto S.; Tezuka K.; Tamatani T.; Narumi S.; Interleukin-1 beta induces tissue- and cell-specific expression of adhesion molecules in vivo. Arterioscler Thromb Vasc Biol 1998,18,1292-1303","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"ref=66","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/0021-9150(90)90089-2","volume":"84","author":"Ikeda U.","year":"1990","unstructured":"Ikeda U.; Ikeda M.; Oohara T.; Kano S.; Yaginuma T.; Mitogenic action of interleukin-1 alpha on vascular smooth muscle cells mediated by PDGF. Atherosclerosis 1990,84,183-188","journal-title":"Atherosclerosis"},{"key":"ref=67","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1007\/BF00404070","volume":"36","author":"Young M.J.","year":"1993","unstructured":"Young M.J.; Adams J.E.; Anderson G.F.; Boulton A.J.; Cavanagh P.R.; Medial arterial calcification in the feet of diabetic patients and matched non-diabetic control subjects. Diabetologia 1993,36,615-621","journal-title":"Diabetologia"},{"key":"ref=68","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/s00223-003-0011-y","volume":"74","author":"Sattler A.M.","year":"2004","unstructured":"Sattler A.M.; Schoppet M.; Schaefer J.R.; Hofbauer L.C.; Novel aspects on RANK ligand and osteoprotegerin in osteoporosis and vascular disease. Calcif Tissue Int 2004,74,103-106","journal-title":"Calcif Tissue Int"},{"key":"ref=69","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1161\/01.ATV.0000012303.37971.DA","volume":"22","author":"Schoppet M.","year":"2002","unstructured":"Schoppet M.; Preissner K.T.; Hofbauer L.C.; RANK ligand and osteoprotegerin: paracrine regulators of bone metabolism and vascular function. Arterioscler Thromb Vasc Biol 2002,22,549-553","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"ref=70","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/S1359-6101(03)00027-3","volume":"14","author":"Walsh M.C.","year":"2003","unstructured":"Walsh M.C.; Choi Y.W.; Biology of the TRANCE axis. Cytokine Growth Factor Rev 2003,14,251-263","journal-title":"Cytokine Growth Factor Rev"},{"key":"ref=71","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.yjmcc.2003.09.015","volume":"36","author":"Kaden J.J.","year":"2004","unstructured":"Kaden J.J.; Bickelhaupt S.; Grobholz R.; Receptor activator of nuclear factor kappaB ligand and osteoprotegerin regulate aortic valve calcification. J Mol Cell Cardiol 2004,36,57-66","journal-title":"J Mol Cell Cardiol"},{"key":"ref=72","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.1096\/fj.02-1188fje","volume":"17","author":"Breuil V.","year":"2003","unstructured":"Breuil V.; Schmid-Antomarchi H.; Schmid-Alliana A.; Rezzonico R.; Euller-Ziegler L.; Rossi B.; The receptor activator of nuclear factor [NF]-kappaB ligand [RANKL] is a new chemotactic factor for human monocytes. FASEB J 2003,17,1751-1753","journal-title":"FASEB J"},{"key":"ref=73","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1161\/01.ATV.16.8.978","volume":"16","author":"Lehto S.","year":"1996","unstructured":"Lehto S.; Niskanen L.; Suhonen M.; R\u00f6nnemaa T.; Laakso M.; Medial artery calcification. A neglected harbinger of cardiovascular complications in non-insulin-dependent diabetes mellitus. Arterioscler Thromb Vasc Biol 1996,16,978-983","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"ref=74","doi-asserted-by":"crossref","first-page":"8","DOI":"10.2337\/diacare.11.1.8","volume":"11","author":"Nelson R.G.","year":"1988","unstructured":"Nelson R.G.; Gohdes D.M.; Everhart J.E.; Lower-extremity amputations in NIDDM. 12-yr follow-up study in Pima Indians. Diabetes Care 1988,11,8-16","journal-title":"Diabetes Care"},{"key":"ref=75","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1007\/BF00404070","volume":"36","author":"Young M.J.","year":"1993","unstructured":"Young M.J.; Adams J.E.; Anderson G.F.; Boulton A.J.M.; Cavanagh P.R.; Medial arterial calcification in the feet of diabetic patients and matched nondiabetic control subjects. Diabetologia 1993,36,615-621","journal-title":"Diabetologia"},{"key":"ref=76","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1007\/s11892-003-0049-2","volume":"3","author":"Chen N.X.","year":"2003","unstructured":"Chen N.X.; Moe S.M.; Arterial calcification in diabetes. Curr Diab Rep 2003,3,28-32","journal-title":"Curr Diab Rep"},{"key":"ref=77","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1016\/j.metabol.2006.08.012","volume":"55","author":"Costacou T.","year":"2006","unstructured":"Costacou T.; Huskey N.D.; Edmundowicz D.; Stolk R.; Orchard T.J.; Lower extremity arterial calcification as a correlate of coronary artery calcification. Metabolism 2006,55,1689-1696","journal-title":"Metabolism"},{"key":"ref=78","first-page":"685","volume":"101","author":"Khanolkar MP","year":"2008","unstructured":"Khanolkar MP; Bain SC; Stephens JW;  The diabetic foot 2008,101,685-95","journal-title":"The diabetic foot"},{"key":"ref=79","first-page":"587","volume":"51","author":"Pitocco D.","year":"2014","unstructured":"Pitocco D.; Marano R.; Di Stasio E.; Atherosclerotic coronary plaque in subjects with diabetic neuropathy: the prognostic cardiovascular role of Charcot neuroarthropathy\u2014a case-control study. Acta Diabetol 2014,51,587-593","journal-title":"Acta Diabetol"},{"key":"ref=80","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1007\/s00109-005-0688-7","volume":"83","author":"Bierhaus A.","year":"2005","unstructured":"Bierhaus A.; Humpert P.M.; Morcos M.; Understanding RAGE, the receptor for advanced glycation end products. J Mol Med 2005,83,876-886","journal-title":"J Mol Med"},{"key":"ref=81","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1177\/107110079902000905","volume":"20","author":"Pinzur M.","year":"1999","unstructured":"Pinzur M.; Benchmark analysis of diabetic patients with neuropathic [Charcot] foot deformity. Foot Ankle Int 1999,20,564-567","journal-title":"Foot Ankle Int"},{"key":"ref=82","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1038\/nature05485","volume":"444","author":"Hotamisligil G.S.","year":"2006","unstructured":"Hotamisligil G.S.; Inflammation and metabolic disorders. Nature 2006,444,860-867","journal-title":"Nature"},{"key":"ref=83","doi-asserted-by":"crossref","first-page":"2014","DOI":"10.1038\/oby.2009.113","volume":"17","author":"Nijhuis J.","year":"2009","unstructured":"Nijhuis J.; Rensen S.S.; Slaats Y.; van Dielen F.M.; Buurman W.A.; Greve J.W.; Neutrophil activation in morbid obesity, chronic activation of acute inflammation. Obesity 2009,17,2014-2018","journal-title":"Obesity"},{"key":"ref=84","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1007\/s10753-014-9914-1","volume":"37","author":"Ghigliotti G.","year":"2014","unstructured":"Ghigliotti G.; Barisione C.; Garibaldi S.; Adipose tissue immune response: noveltriggers and consequences for chronicinflammatoryconditions. Inflammation 2014,37,1337-1353","journal-title":"Inflammation"},{"key":"ref=85","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.foot.2014.05.003","volume":"24","author":"La Fontaine J.","year":"2014","unstructured":"La Fontaine J.; Bhavan K.; Talal T.K.; Lavery L.A.; Current concepts in the surgical management of acute diabetic foot infections. Foot 2014,24,123-127","journal-title":"Foot"},{"key":"ref=86","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.1172\/JCI200319451","volume":"112","author":"Xu H.","year":"2003","unstructured":"Xu H.; Barnes G.T.; Yang Q.; Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. J Clin Invest 2003,112,1821-1830","journal-title":"J Clin Invest"},{"key":"ref=87","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.2337\/dc11-0396","volume":"34","author":"Pakarinen T.K.","year":"2011","unstructured":"Pakarinen T.K.; Laine H.J.; M\u00e4enp\u00e4 H.; Mattila P.; Lahtela J.; The effect of zoledronic acid on the clinical resolution of charcotneuroarthropathy: a pilot randomized controlled trial. Diabetes Care 2011,34,1514-1516","journal-title":"Diabetes Care"},{"key":"ref=88","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1016\/j.amjmed.2008.06.038","volume":"121","author":"Stuck R.M.","year":"2008","unstructured":"Stuck R.M.; Sohn M.W.; Budiman-Mak E.; Lee T.A.; Weiss K.B.; Charcot arthropathy risk elevation in the obese diabetic population. Am J Med 2008,121,1008-1014","journal-title":"Am J Med"},{"key":"ref=89","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1053\/j.jfas.2012.10.003","volume":"52","author":"Ross A.J.","year":"2013","unstructured":"Ross A.J.; Mendicino R.W.; Catanzariti A.R.; Role of body mass index in acute charcotneuroarthropathy. J Foot Ankle Surg 2013,52,6-8","journal-title":"J Foot Ankle Surg"},{"key":"ref=90","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1093\/ptj\/77.2.169","volume":"77","author":"Armstrong D.G.","year":"1997","unstructured":"Armstrong D.G.; Lavery L.A.; Liswood P.J.; Todd W.F.; Tredwell J.A.; Infrared dermal thermometry for the high-risk diabetic foot. Phys Ther 1997,77,169-175","journal-title":"Phys Ther"},{"key":"ref=91","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1002\/(SICI)1096-9136(199705)14:5<357::AID-DIA341>3.0.CO;2-8","volume":"14","author":"Armstrong D.G.","year":"1997","unstructured":"Armstrong D.G.; Todd W.F.; Lavery L.A.; Harkless L.B.; Bushman T.R.; The natural history of acute Charcot\u2019s arthropathy in a diabetic foot specialty clinic. Diabet Med 1997,14,357-363","journal-title":"Diabet Med"},{"key":"ref=92","doi-asserted-by":"crossref","first-page":"381","DOI":"10.7547\/87507315-92-7-381","volume":"92","author":"Jude E.B.","year":"2002","unstructured":"Jude E.B.; Boulton A.J.; Medical treatment of Charcot\u2019s arthropathy. J Am Podiatr Med Assoc 2002,92,381-383","journal-title":"J Am Podiatr Med Assoc"},{"key":"ref=93","author":"Najafi B.","year":"2012","unstructured":"Najafi B.; Wrobel J.S.; Grewal G.; Temperature response to walking in diabetes with and without acute Charcot: the Charcot Activity Response test. J Aging Res 2012","journal-title":"J Aging Res"},{"key":"ref=94","doi-asserted-by":"crossref","first-page":"210","DOI":"10.7547\/87507315-92-4-210","volume":"92","author":"Yu G.V.","year":"2002","unstructured":"Yu G.V.; Hudson J.R.; Evaluation and Treatment of Stage 0 Charcot\u2019s Neuroarthropathy of the Foot and Ankle. J Am Podiatr Med Assoc 2002,92,210-220","journal-title":"J Am Podiatr Med Assoc"},{"key":"ref=95","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.cpm.2008.01.002","volume":"25","author":"Rogers L.C.","year":"2008","unstructured":"Rogers L.C.; Bevilacqua N.J.; Imaging of the Charcot foot. Clin Podiatr Med Surg 2008,25,263-274","journal-title":"Clin Podiatr Med Surg"},{"key":"ref=96","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1259\/bjr\/30036666","volume":"80","author":"Tan P.L.","year":"2007","unstructured":"Tan P.L.; Teh J.; MRI of the diabetic foot: differentiation of infection from neuropathic change. Br J Radiol 2007,80,939-948","journal-title":"Br J Radiol"},{"key":"ref=97","first-page":"4","volume":"20","author":"Ergen F.B.","year":"2013","unstructured":"Ergen F.B.; Sanverdi S.E.; Oznur A.; Charcot foot in diabetes and an update on imaging. Diabet Foot Ankle 2013,20,4","journal-title":"Diabet Foot Ankle"},{"key":"ref=98","doi-asserted-by":"crossref","DOI":"10.3402\/dfa.v4i0.21855","volume":"4","author":"Ertugrul BM","year":"2013","unstructured":"Ertugrul BM; Lipsky BA; Savk O; Osteomyelitis or Charcot neuro-osteoarthropathy? Differentiating these disorders in diabetic patients with a foot problem. Diabet Foot Ankle 2013,4","journal-title":"Diabet Foot Ankle"},{"key":"ref=99","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1177\/107110079601700103","volume":"17","author":"Johnson J.E.","year":"1996","unstructured":"Johnson J.E.; Kennedy E.J.; Shereff M.J.; Patel N.C.; Collier B.D.; Prospective study of bone, indium-111-labeled white blood cell, and gallium-67 scanning for the evaluation of osteomyelitis in the diabetic foot. Foot Ankle Int 1996,17,10-16","journal-title":"Foot Ankle Int"},{"key":"ref=100","first-page":"346","volume":"39","author":"Palestro C.J.","year":"1998","unstructured":"Palestro C.J.; Mehta H.H.; Patel M.; Marrow versus infection in the Charcot joint: indium-111 leukocyte and technetium-99m sulfur colloid scintigraphy. J Nucl Med 1998,39,346-350","journal-title":"J Nucl Med"},{"key":"ref=101","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1055\/s-0038-1623931","volume":"45","author":"H\u00f6pfner S.","year":"2006","unstructured":"H\u00f6pfner S.; Krolak C.; Kessler S.; Tiling R.; Preoperative imaging of Charcot neuroarthropathy: does the additional application of [18]F-FDG-PET make sense? Nuklearmedizin 2006,45,15-20","journal-title":"Nuklearmedizin"},{"key":"ref=102","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1097\/MNM.0b013e328174447f","volume":"28","author":"Basu S.","year":"2007","unstructured":"Basu S.; Chryssikos T.; Houseni M.; Potential role of FDG PET in the setting of diabetic neuro-osteoarthropathy: can it differentiate uncomplicated Charcot\u2019s neuroarthropathy from osteomyelitis and soft-tissue infection? Nucl Med Commun 2007,28,465-472","journal-title":"Nucl Med Commun"},{"key":"ref=103","first-page":"18","volume":"13","author":"Ranachowska C.","year":"2010","unstructured":"Ranachowska C.; Lass P.; Korzon-Burakowska A.; Dobosz M.; Diagnostic imaging of the diabetic foot. Nucl Med Rev Cent East Eur 2010,13,18-22","journal-title":"Nucl Med Rev Cent East Eur"},{"key":"ref=104","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1053\/j.semnuclmed.2009.08.005","volume":"40","author":"van der Bruggen W.","year":"2010","unstructured":"van der Bruggen W.; Bleeker-Rovers C.P.; Boerman O.C.; Gotthardt M.; Oyen W.J.; PET and SPECT in osteomyelitis and prosthetic bone and joint infections: a systematic review. Semin Nucl Med 2010,40,3-15","journal-title":"Semin Nucl Med"},{"key":"ref=105","first-page":"444","volume":"46","author":"Keidar Z.","year":"2005","unstructured":"Keidar Z.; Militianu D.; Melamed E.; Bar-Shalom R.; Israel O.; The diabetic foot: initial experience with 18F-FDG PET\/CT. J Nucl Med 2005,46,444-449","journal-title":"J Nucl Med"},{"key":"ref=106","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1097\/00003072-200004000-00009","volume":"25","author":"Zhuang H.","year":"2000","unstructured":"Zhuang H.; Duarte P.S.; Pourdehand M.; Shnier D.; Alavi A.; Exclusion of chronic osteomyelitis with F-18 fluorodeoxyglucose positron emission tomographic imaging. Clin Nucl Med 2000,25,281-284","journal-title":"Clin Nucl Med"},{"key":"ref=107","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1055\/s-0038-1623931","volume":"45","author":"H\u00f6pfner S.","year":"2006","unstructured":"H\u00f6pfner S.; Krolak C.; Kessler S.; Tiling R.; Preoperative imaging of Charcot neuroarthropathy: does the additional application of [18]F-FDG-PET make sense? Nuklearmedizin 2006,45,15-20","journal-title":"Nuklearmedizin"},{"key":"ref=108","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1177\/0309364614560939","volume":"39","author":"Idusuyi O.B.","year":"2015","unstructured":"Idusuyi O.B.; Surgical management of Charcot Neuroarthropathy. Prosthet and Orthot Int 2015,39,61-72","journal-title":"Prosthet and Orthot Int"},{"key":"ref=109","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1080\/00325481.1991.11700869","volume":"89","author":"Giurini J.M.","year":"1991","unstructured":"Giurini J.M.; Chrzan J.S.; Gibbons G.W.; Habershaw G.M.; Charcot\u2019s disease in diabetic patients. Correct diagnosis can prevent progressive deformity. Postgrad Med 1991,89,163-169","journal-title":"Postgrad Med"},{"key":"ref=110","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1097\/00005792-197205000-00006","volume":"51","author":"Sinha S.","year":"1972","unstructured":"Sinha S.; Munichoodappa C.S.; and Kozak G.P.; Neuroarthropathy (Charcot joints) in diabetes mellitus (clinical study of 101 cases). Medicine 1972,51,191-210","journal-title":"Medicine"},{"key":"ref=111","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/s00132-014-3055-y","volume":"44","author":"Trieb K.","year":"2015","unstructured":"Trieb K.; Ramadani F.; Hofstaetter S.G.; Full contact plaster cast for conservative treatment of Charcot foot. Orthopade 2015,44,39-44","journal-title":"Orthopade"},{"key":"ref=112","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.fas.2007.10.002","volume":"14","author":"Verity S.","year":"2008","unstructured":"Verity S.; Sochocki M.; Embil J.M.; Trepman E.; Treatment of Charcot foot and ankle with a prefabricated removable walker brace and custom insole. Foot and Ankle Surg 2008,14,26-31","journal-title":"Foot and Ankle Surg"},{"key":"ref=113","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1177\/107110070602700503","volume":"27","author":"Pinzur M.S.","year":"2006","unstructured":"Pinzur M.S.; Lio T.; Matthew Posner M.; Treatment of eichenholtz stage I charcot foot arthropathy with a weight bearing total contact cast. Foot Ankle Int 2006,27,324-329","journal-title":"Foot Ankle Int"},{"key":"ref=114","doi-asserted-by":"crossref","first-page":"2032","DOI":"10.1007\/s001250100008","volume":"44","author":"Jude E.B.","year":"2001","unstructured":"Jude E.B.; Selby P.L.; Burgess J.; Lilleystone P.; Mawer E.B.; Page S.R.; Bisphosphonates in the treatment of Charcot neuroarthropathy: double blinded randomised controlled trial. Diabetologia 2001,44,2032-2037","journal-title":"Diabetologia"},{"key":"ref=115","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.2337\/diacare.28.5.1214","volume":"28","author":"Pitocco D.","year":"2005","unstructured":"Pitocco D.; Ruotolo V.; Caputo S.; Mancini L.; Collina C.M.; Manto A.; Six month treatment with alendronate in acute Charcot neuroarthropathy: a randomized controlled trial. Diabetes Care 2005,28,1214-1215","journal-title":"Diabetes Care"},{"key":"ref=116","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.fas.2012.12.007","volume":"19","author":"Pakarinen T-K.","year":"2013","unstructured":"Pakarinen T-K.; Laine H-J.; M\u00e4enp\u00e4 H.; K\u00e4h\u00f6nen M.; Mattila P.; Lahtela J.; Effect of immobilization, off-loading and zoledronic acid on bone mineral density in patients with acute Charcot neuroarthropathy: A prospective randomized trial. Foot and Ankle Surg 2013,19,121-124","journal-title":"Foot and Ankle Surg"},{"key":"ref=117","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.2337\/dc06-0376","volume":"29","author":"Bern R.","year":"2006","unstructured":"Bern R.; Jirkovska A.; Fejfarova V.; Skibova J.; Jude E.B.; Intranasal calcitonin in the treatment of acute Charcot neurosteoarthropathy: a randomized controlled trial. Diabetes Care 2006,29,1392-1395","journal-title":"Diabetes Care"},{"key":"ref=118","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.diabet.2010.04.002","volume":"36","author":"Molines L.","year":"2010","unstructured":"Molines L.; Darmon P.; Raccah D.; Charcot\u2019s foot: Newest findings on its pathophysiology, diagnosis and treatment. Diabetes Metab 2010,36,251-255","journal-title":"Diabetes Metab"},{"key":"ref=119","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1007\/s11999-009-0972-x","volume":"468","author":"Mittlmeier T.","year":"2010","unstructured":"Mittlmeier T.; Klaue K.; Haar P.; Beck M.; Should one consider primary surgical reconstruction in Charcot arthropathy of the feet? Clin Orthop Relat Res 2010,468,1002-1011","journal-title":"Clin Orthop Relat Res"},{"key":"ref=120","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1177\/145749690209100212","volume":"91","author":"Pakarinen T.K.","year":"2002","unstructured":"Pakarinen T.K.; Laine H.J.; Honkonen S.E.; Peltonen J.; Oksana H.; Lahtela J.; Charcot arthropathy of the diabetic foot: current concepts and review of 36 cases. Scand J Surg 2002,91,195-201","journal-title":"Scand J Surg"},{"key":"ref=121","doi-asserted-by":"crossref","first-page":"147","DOI":"10.2337\/diacare.22.1.147","volume":"22","author":"Kalani M.","year":"1999","unstructured":"Kalani M.; Brismar K.; Fagrell B.; Ostergren J.; J\u00f6rneskog G.; Transcutaneous oxygen tension and toe blood pressure as predictors for outcome of diabetic foot ulcers. Diabetes Care 1999,22,147-151","journal-title":"Diabetes Care"},{"key":"ref=122","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1097\/00003086-199804000-00015","author":"Schon L.C.","year":"1998","unstructured":"Schon L.C.; Easley M.E.; Weinfeld S.B.; Charcot neuroarthropathy of the foot and ankle. Clin Orthop Relat Res 1998(349),116-131","journal-title":"Clin Orthop Relat Res"},{"key":"ref=123","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/S1067-2516(00)80045-9","volume":"39","author":"Catanzariti A.R.","year":"2000","unstructured":"Catanzariti A.R.; Mendicino R.; Haverstock B.; Ostectomy for diabetic neuroarthropathy involving the midfoot. J Foot Ankle Surg 2000,39,291-300","journal-title":"J Foot Ankle Surg"},{"key":"ref=124","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/S1083-7515(02)00019-0","volume":"7","author":"Cooper P.S.","year":"2002","unstructured":"Cooper P.S.; Application of external fixators for management of Charcot deformities of the foot and ankle. Foot Ankle Clin N Am 2002,7,207-254","journal-title":"Foot Ankle Clin N Am"},{"key":"ref=125","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1053\/j.jfas.2010.12.002","volume":"50","author":"Grant W.P.","year":"2011","unstructured":"Grant W.P.; Garcia-Lavin S.; Sabo R.; Beaming the Columns for Charcot Diabetic Foot Reconstruction: A Retrospective Analysis. J Foot Ankle Surg 2011,50,182-189","journal-title":"J Foot Ankle Surg"},{"key":"ref=126","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1097\/01.ASW.0000323576.41959.8e","volume":"21","author":"Zgonis T.","year":"2008","unstructured":"Zgonis T.; Roukis T.S.; Stapleton J.J.; Cromack D.T.; Combined lateral column arthrodesis, medial plantar artery flap, and circular external fixation for Charcot midfoot collapse with chronic plantar ulceration. Adv Skin Wound Care 2008,21,521-525","journal-title":"Adv Skin Wound Care"},{"key":"ref=127","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1016\/j.cursur.2005.03.016","volume":"62","author":"Sayner R.L.","year":"2005","unstructured":"Sayner R.L.; Rosenblum B.I.; External fixation for charcot foot reconstruction. Curr Surg 2005,62,618-623","journal-title":"Curr Surg"},{"key":"ref=128","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/j.cpm.2006.01.008","volume":"23","author":"Roukis T.S.","year":"2006","unstructured":"Roukis T.S.; Zgonis T.; The management of acute Charcot fracture-dislocations with the Taylor\u2019s spatial external fixation system. Clin Podiatr Med Surg 2006,23,467-483","journal-title":"Clin Podiatr Med Surg"},{"key":"ref=129","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1016\/j.fcl.2006.06.006","volume":"11","author":"Pinzur M.S.","year":"2006","unstructured":"Pinzur M.S.; The role of ring external fixation in Charcot foot arthropathy. Foot Ankle Clin 2006,11,837-847","journal-title":"Foot Ankle Clin"},{"key":"ref=130","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.fas.2011.10.006","volume":"18","author":"Altindas M.","year":"2012","unstructured":"Altindas M.; Kilic A.; Ceber M.; A new limb-salvaging technique for the treatment of late stage complicated Charcot foot deformity: two-staged Boyd\u2019s operation. Foot Ankle Surg 2012,18,190-194","journal-title":"Foot Ankle Surg"}],"container-title":["Current Diabetes Reviews"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/eurekaselect.com\/article\/download\/171943","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,1,8]],"date-time":"2020-01-08T18:55:34Z","timestamp":1578509734000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.eurekaselect.com\/171943\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12,13]]},"references-count":130,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12,13]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1573399815666190502121945","relation":{},"ISSN":["1573-3998"],"issn-type":[{"value":"1573-3998","type":"print"}],"subject":[],"published":{"date-parts":[[2019,12,13]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2018-11-16","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-03-26","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-04-17","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-12-13","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}